Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Mind Medicine (MindMed) Inc
MNMD
Alternate Symbol(s):
N.MMED.WS
|
N.MMED
|
N.MMED.WA
|
N.MMED.WR
Healthcare
Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen...
drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:MNMD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 23, 2022 9:59am
New Press Release - IIROC Trade Resumption - MMED
TORONTO, Aug. 23, 2022 /CNW/ - Trading resumes in:Company: MIND MEDICINE (MINDMED) INC.NEO Exchange Symbol: MMEDAll Issues: NoResumption (ET): 9:39:10 AMIIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 23, 2022 9:51am
New Press Release - IIROC Trading Halt - MMED
TORONTO, Aug. 23, 2022 /CNW/ - The following issues have been halted by IIROC:Company: MIND MEDICINE (MINDMED) INC.NEO Exchange Symbol : MMEDAll Issues: YesReason: Single-Stock Circuit BreakerHalt Time (ET): 09:34:10 AMIIROC can make a decision to impose a temporary suspension (halt) of trading...
read article.
(37)
•••
MrVerbatim9800
X
View Profile
View Bullboard History
Post by
MrVerbatim9800
on Aug 18, 2022 12:48pm
Why Mind Medicine (MindMed) Stock Is Crushing It Today
Mind Medicine (MindMed) (NASDAQ: MNMD) stock is absolutely crushing it on Thursday, with shares soaring 45.4% as of 11:20 a.m. ET after rising as much as 77.3% earlier in the day. The
...more
(258)
•••
sollmg
X
View Profile
View Bullboard History
Post by
sollmg
on Aug 18, 2022 11:20am
MSN Article
Article. talks about short squeeze and $3 pre-split price target https://www.msn.com/en-us/money/topstocks/is-mindmed-mnmd-stock-the-next-big-short-squeeze/ar-AA10NTGK
(37)
•••
MrVerbatim9800
X
View Profile
View Bullboard History
Comment by
MrVerbatim9800
on Aug 18, 2022 10:50am
RE:Mind Medicine (MNMD) Stock: Why It Surged Over 70% Today
Love it..... ;)
(37)
•••
MrVerbatim9800
X
View Profile
View Bullboard History
Comment by
MrVerbatim9800
on Aug 18, 2022 10:26am
RE:What is happening today?
Losses cut by nearly 1/3 ! That's awesome. New CEO that actually has drive and getting us out there again. Recognition that we need to increase our position for the listing etc..... Lot's of
...more
(42)
•••
thedave2006
X
View Profile
View Bullboard History
Post by
thedave2006
on Aug 18, 2022 10:13am
gamma
nothing more.
(23)
•••
Alim33
X
View Profile
View Bullboard History
Post by
Alim33
on Aug 18, 2022 9:52am
What is happening today?
I don't see any news?
(433)
•••
AwareInvestor
X
View Profile
View Bullboard History
Post by
AwareInvestor
on Aug 12, 2022 8:22am
MindMed Declares US$17.0 Million Net Loss, US$105.7 Million
Mind Medicine Inc, more commonly known as MindMed, announced on Thursday its financial results for Q2 2022. The biotech company ended the quarter with an incurred net loss of US$17.0 million compared
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 12, 2022 7:30am
New Press Release - MindMed Strengthens Board with Appointment of Two New Independent Directors
NEW YORK, Aug. 12, 2022 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company"), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced the appointment of Dr. Suzanne Bruhn and Dr. Roger Crystal...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 11, 2022 4:06pm
New Press Release - MindMed Reports Second Quarter 2022 Financial Results and Business Highlights
– Phase 2b dose-optimization trial in patients with General Anxiety Disorder underway with first patient dosing expected in Q3 2022 –– Advanced IND-enabling studies for MM-402 with the Phase 1 investigator-initiated pharmacokinetic/pharmacodynamic trial on track to initiate in Q3 2022 –– Appoints...
read article.
(433)
•••
AwareInvestor
X
View Profile
View Bullboard History
Post by
AwareInvestor
on Aug 11, 2022 8:45am
Mind Medicine Sees Co-Founder Become An Activist Shareholder
An activist shareholder battle might be brewing at Mind Medicine. This morning, co-founder of the company Dr Scott Freeman, via his holding company FCM MM Holdings, LLC, issued a release calling for
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 11, 2022 8:08am
New Press Release - MindMed Co-Founder Dr. Scott Freeman Proposes Value Enhancement Plan
SHERIDAN, Wyo., Aug. 11, 2022 /PRNewswire/ -- Today, FCM MM HOLDINGS, LLC ("FCM") announced that it has sent a letter to the Board of Directors of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) (the "Company" or "MindMed") calling on the Board to adopt a new strategic plan proposed by FCM including...
read article.
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Comment by
Bullknit101
on Aug 10, 2022 8:00am
RE:Mindmed To Conduct 15-To-1 Reverse Split To Meet Nasdaq List
Once the do the split, although they will mee the NASDAQ listing requirements, the stock will likely have room to tumble even more. The best strategy is to grab the train on the way out of the station
...more
(433)
•••
AwareInvestor
X
View Profile
View Bullboard History
Post by
AwareInvestor
on Aug 05, 2022 8:43am
Mindmed To Conduct 15-To-1 Reverse Split To Meet Nasdaq List
In a classic Canadian small cap move, Mind Medicine last night announced that it’s directors have approved a share consolidation. The consolidation follows an announcement in May that the company
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Xcyte Digital Corp. Releases "Xperience" Subscription Service
Drilling Approval Received for New Mexico Lithium Project
GameSquare Announces Formation of FaZe Media, Backed by $11M Investment